As discussed later, there is evidence suggesting that CK1α negatively regulates p53 signalling [45,46]; therefore, in the absence of p53 perhaps CK1α acts as a tumour suppressor, and when the expression of CSNK1A1 is low, tumour survival is enhanced. The gene discussed is CSNK1A1; the disease is neoplasm.